Spurred on by global ambitions of its top players, formidable core competencies and an evolving global marketplace, the Indian pharmaceutical industry is perhaps at inflection point towards a phase of high value growth with increasing international revenues and the emergence of innovative business models. Dr Brian Tempest – former Chief Mentor and Executive Vice Chairman of Ranbaxy Laboratories is particularly well placed to draw on his experiences both at Ranbaxy – one of the world’s largest generic pharmaceutical companies and within global pharmaceutical leadership roles over 37 years, to discuss what future leading Indian pharmaceutical companies will look like, and what opportunities this presents for UK R&D.

Professor Barry Furr, former Chief Scientific Officer at Astra Zeneca, well versed with pharmaceutical R&D across the world including notably Astra Zeneca’s Tuberculosis Research Center in Bangalore will moderate the discussion raising pertinent questions. This event will be a unique opportunity to learn the views of two experienced industry veterans about a group of companies that could well shake up the global industry.

Registration required:

Yes

Free:

No